Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like Volpara To Showcase Volpara Enterprise DDP Software At July 11, 2017 Where High-Flying Cara Therapeutics Could be in 5 Years October 5, 2017 Novartis Eyes 2019 for Launch of Investigational nAMD treatment February 21, 2018
